Article
Ketosynthase III as a gateway to engineering the biosynthesis of antitumoral benastatin derivatives.
Journal of biotechnology - 10 Mar 2009
Xu Zhongli, Metsä-Ketelä Mikko, Hertweck Christian
Abstract excerpt
Benastatins are aromatic polyketides from Streptomyces spp. that efficiently inhibit glutathione-S-transferases and induce apoptosis. Their biosynthesis involves a type II polyketide synthase, and a ketoacyl synthase (KAS) III component (BenQ) similar to FabH that is crucial for providing and selecting the rare hexanoate PKS starter unit. The function of BenQ as a KAS III was experimentally proven by point...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
